CASP3 and liver cancer: Meanwhile, we observed that Lenvatinib and Pulrodemstat co-treatment led to the significantly elevated of cleaved caspase 3 without affecting the total caspase 3 expression in both liver cancer cell lines (Fig. 4D, E).